Myriad Genetics Inc (MYGN): Cash & Equivalents
$149.60M
As of 2025-12-31
$115.20M
As of 2026-06-30
+38.0%
3-year compound annual growth
+5.0%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $149.60M | +46.1% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $102.40M | -22.5% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $132.10M | +132.2% | 2026-02-24, Balance as of period end |
| 2022-12-31 | $56.90M | -77.9% | 2025-02-28, Balance as of period end |
| 2021-12-31 | $257.40M | +120.0% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $117.00M | n/a | 2023-03-01, Balance as of period end |
| 2020-06-30 | $163.70M | +75.6% | 2023-03-01, Balance as of period end |
| 2019-06-30 | $93.20M | -16.0% | 2020-08-13, Balance as of period end |
| 2018-06-30 | $110.90M | +8.3% | 2019-08-13, Balance as of period end |
| 2017-06-30 | $102.40M | +49.5% | 2019-08-13, Balance as of period end |
| 2016-06-30 | $68.50M | +6.9% | 2018-08-24, Balance as of period end |
| 2015-06-30 | $64.10M | -1.1% | 2018-08-24, Balance as of period end |
| 2014-06-30 | $64.80M | -37.8% | 2016-08-10, Balance as of period end |
| 2013-06-30 | $104.10M | +20.6% | 2015-08-12, Balance as of period end |
| 2012-06-30 | $86.35M | +63.9% | 2014-08-13, Balance as of period end |
| 2011-06-30 | $52.68M | -43.3% | 2013-08-14, Balance as of period end |
| 2010-06-30 | $92.84M | +46.2% | 2012-08-15, Balance as of period end |
| 2009-06-30 | $63.51M | n/a | 2011-08-15, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $149.60M | +46.1% |
| Neogen Corp (NEOG) | 2026-05-31 | $185.50M | +43.8% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $359.12M | -60.7% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $169.80M | +72.7% |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $180.07M | -37.5% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $155.46M | -17.8% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $5.91M | +59.4% |
| Immucell Corp (ICCC) | 2025-12-31 | $3.81M | +1.3% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $1.75M | -0.8% |
Compare MYGN, NEOG, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗